Helicobacter pyloritherapy: what is coming?

This publication has 41 references indexed in Scilit:

• Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three‐way crossover study
  Alimentary Pharmacology & Therapeutics, 2006
• Efficacy of Moxifloxacin‐Based Triple Therapy as Second‐Line Treatment for Helicobacter pylori Infection
  Helicobacter, 2006
• Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
  Alimentary Pharmacology & Therapeutics, 2005
• Evaluation of the Antimicrobial Effects of Several Isothiocyanates onHelicobacter pylori
  Planta Medica, 2005
• H pylori antibiotic resistance: prevalence, importance, and advances in testing
  Gut, 2004
• Helicobacter pylori Infection and Immune Thrombocytopenic Purpura: an Update
  Helicobacter, 2004
• Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States
  Digestive and Liver Disease, 2004
• Quadruple therapy as a first-line Helicobacter pylori treatment: past or future?
  Digestive and Liver Disease, 2004
• Efficacyof Sulforaphane in EradicatingHelicobacter pyloriin HumanGastric Xenografts Implanted in NudeMice
  Antimicrobial Agents and Chemotherapy, 2003
• The optimal antibiotic combination in a 5‐day Helicobacter pylori eradication regimen
  Alimentary Pharmacology & Therapeutics, 1999